Skip to main content

Advertisement

Log in

Novel ibuprofen prodrugs with improved pharmacokinetics and non-ulcerogenic potential

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

In the present study, we evaluated the anti-inflammatory activity with pharmacokinetic, ulcerogenic properties of various synthesized prodrugs of ibuprofen in experimental animals. Prodrugs 2, 6, 9, 10, 12, and 14 were found to possess significant anti-inflammatory activity with almost non-ulcerogenic potential than standard drug ibuprofen 1a in both normal and inflammation-induced rats. Metabolic stability of prodrugs 2, 6, 9, 10, 12, and 14 were also studied in rat liver microsomes and oral bioavailability was determined by estimating area under curve (AUC) and plasma concentration of these prodrugs at various time intervals. The experimental findings elicited higher AUC and plasma concentration at 1 and 2 h indicating improved oral bioavailability as compared to parent ibuprofen. These prodrugs are found to have least gastric ulceration with retain anti-inflammatory activity observed in experimental animals. Therefore, present experimental findings demonstrated significant improvement of various pharmacokinetic properties with least ulcerogenic potential of ester prodrugs of ibuprofen an anti-inflammatory agent

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Scheme 1
Scheme 2
Scheme 3
Scheme 4
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Abbreviations

NSAID:

Nonsteroidal anti-inflammatory drug

Tris–HCl:

Tris(hydroxymethyl)aminomethane hydrochloride

NADPH:

Nicotinamide adenine dinucleotide phosphate

HPLC:

High performance liquid chromatography

GC:

Gas chromatography

RLM:

Rat liver microsomes

RP:

Rat plasma

API:

Active pharmaceutical ingredient

UI:

Ulcer index

GI:

Gastrointestinal

DMAc:

Dimethyl acetamide

PTSA:

p-Toluene sulfonic acid

PXRD:

Powder X-ray diffraction

RT:

Room temperature

TMG:

1,1,3,3-Tetramethyl guanidine

18 Crown 6:

1,4,7,10,13,16-Hexaoxacyclooctadecane

EP:

European pharmacopoeia

Ar:

Aromatic

BDL:

Below detection limit

References

  • Abordo EA, Bowden K, Huntington AP, Powell SL (1998) Prodrugs. Part 3. 2-Formylphenyl esters of indomethacin, ketoprofen and ibuprofen and 6-substituted 2-formyl and 2-acylphenyl esters of aspirin. Farmaco 53:95–101

    Article  CAS  PubMed  Google Scholar 

  • Ashraf E, Ford L, Geetha R, Cooper S (1999) Safety profile of ibuprofen suspension in young children. Inflammopharmacology 7:219–225

    Article  CAS  PubMed  Google Scholar 

  • Bhosale D, Bharambe S, Gairola N, Dhaneshware SS (2006) Mutual prodrug concept: fundamentals and applications. Ind J Pharm Sci 3:286–294

    Google Scholar 

  • Borhade N, Pathan AR, Halder S, Karwa M et al (2012) NO-NSAIDs. Part 3: Nitric oxide-releasing prodrugs of non-steroidal anti-inflammatory drugs. Chem Pharm Bull 60:465–481

    Article  CAS  PubMed  Google Scholar 

  • Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352:1092–1102

    Article  CAS  PubMed  Google Scholar 

  • Bundgaard H (ed) (1986) Design of prodrugs. Elsevier, Amsterdam, pp 49–68

    Google Scholar 

  • Bundgaard H (1989) The double prodrug concept and its applications. Adv Drug Rev 3:39–65

    Article  CAS  Google Scholar 

  • Chen Q, Gong T, Liu J, Wang X, Fu H, Zhang Z (2009) Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery. J Drug Target 17:318–328

    Article  CAS  PubMed  Google Scholar 

  • Cioli V, Putzolu S, Rossi V, Corradino CA (1980) Toxicological and pharmacological study of ibuprofen guaiacol ester (AF 2259) in the rat. Toxicol Appl Pharmacol 54:332–339

    Article  CAS  PubMed  Google Scholar 

  • Coruzzi G, Venturi N, Spaggiarim S (2007) Gastrointestinal safety of novel nonsteroidal anti-inflammatory drugs: selective COX-2 inhibitors and beyond. Acta Biomed 78:96–110

    CAS  PubMed  Google Scholar 

  • Crunckhon P, Meacock SER (1971) Mediators of inflammation induced in rat paw edema by carrageenan. Br J Pharmacol 42:392–402

    Article  Google Scholar 

  • Gairola N, Nagpal D, Dhaneshwar SS, Dhaneshwar SR, Chaturvedi SC (2005) Synthesis, hydrolysis kinetics and pharmacodynamic profile of novel prodrugs of flurbiprofen. Indian J Pharm Sci 67:369–373

    CAS  Google Scholar 

  • Ganguly AK, Bhatnagar OP (1973) Effect of bilateral adrenalactomy on production of resistant ulcers in the stomach of albino rats. Can J Physiol Pharmacol 51:748–750

    Article  CAS  PubMed  Google Scholar 

  • Halen PK, Murumkar PR, Giridhar R, Yadav MR (2009) Prodrug designing of NSAIDs. Mini-reviews in medicinal chemistry 9:124–139

    Article  CAS  PubMed  Google Scholar 

  • Huang Z, Velazquez CA, Abdellatif KRA, Chowdhury MA, Reisz JA, DuMond JF, Bruce King S, Knaus EE (2011) Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal antiinflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies. J Med Chem 54:1356–1364

    Article  CAS  PubMed  Google Scholar 

  • Kawail S, Kojima F, Kusunoki N (2005) Recent advances in non-steroidal anti-inflammatory drugs. Allergol Int 54:209–215

    Article  Google Scholar 

  • Kean WF, Buchanan WW (2005) The use of NSAIDs in rheumatic disorders 2005: a global perspective. Inflammopharmacol 13:343–370

    Article  CAS  Google Scholar 

  • Kim H, Jeon H, Kong H, Yang Y, Choi B, Kim YM, Neckers L, Jung YA (2006) Molecular mechanism for the anti-inflammatory effect of taurine-conjugated 5-aminosalicylic acid in inflamed colon. Mol Pharmacol 69:1405–1412

    Article  CAS  PubMed  Google Scholar 

  • Klasser GD, Epstein J (2005) Nonsteroidal anti-inflammatory drugs: confusion, controversy and dental implications. J Can Dent Assoc 71:575–580

    PubMed  Google Scholar 

  • Mahfouz NM, Omar FA, Aboul-Fadl T (1999) Cyclic amide derivatives as potential prodrugs II: n-hydroxymethylsuccinimide isatin esters of some NSAIDs as prodrugs with an improved therapeutic index. Eur J Med Chem 34:551–562

    CAS  PubMed  Google Scholar 

  • Nielsen NM, Bundgaard H (1988) Glycolamide esters as biolabile prodrugs of carboxylic acid agents: synthesis, stability, bioconversion, and physicochemical properties. J Pharm Sci 77:285–298

    Article  CAS  PubMed  Google Scholar 

  • Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM (2005) Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 352:1081–1091

    Article  CAS  PubMed  Google Scholar 

  • OECD (2006) Organization of Economic and Corporation Development guidelines for the testing of chemicals-acute oral toxicity up and down procedure. p 425

  • Perioli L, Ambrogi V, Bernardini C, Grandolini G, Ricci M, Giovagnoli S, Rossi C (2004) Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS. Eur J Med Chem 39:715–727

    Article  CAS  PubMed  Google Scholar 

  • Rainsford KD (1988) Gastrointestinal damage from nonsteroidal anti-inflammatory drugs toxicol. Pathology 16:251–259

    CAS  Google Scholar 

  • Shaaya O, Magora A, Sheskin T, Kumar N, Domb A (2003) Anhydride prodrugs for nonsteroidal anti-inflammatory drugs. J Pharm Res 20:205–211

    Article  CAS  Google Scholar 

  • Shanbhag VR, Rider AM, Gokhale R, Harpalanai A, Dick RM (1992) Ester and amide prodrugs of ibuprofen and naproxen: synthesis, anti-inflammatory activity, and gastrointestinal toxicity. J Pharm Sci 81:149–154

    Article  CAS  PubMed  Google Scholar 

  • Wallace JL (1994) The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage potential for development of gastrointestinal tract safe NSAIDs. Can J Physiol Pharmacol 72:1493–1498

    Article  CAS  PubMed  Google Scholar 

  • Winter CA, Porter CC (1957) Effect of alteration in side chain on anti-inflammatory and liver glycogen activities of hydrocortisone exters. Am J Pharm Sci 46:515–520

    Article  CAS  Google Scholar 

  • Winter CA, Risley EA, Nuss GW (1962) Carrageenan induced edema in hind paw of rats as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544–547

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors also gratefully acknowledge the support extended by Mr. Ashok Hiremath, Managing Director, Astec Lifesciences Ltd. Authors are also thankful to Dr. S. R. Naik and Dr. S.B. Bhise, Sinhgad Institute of Pharmaceutical Sciences, Lonavala for providing necessary facility for pharmacological experimentation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Babasaheb P. Bandgar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dhakane, V.D., Chavan, H.V., Thakare, V.N. et al. Novel ibuprofen prodrugs with improved pharmacokinetics and non-ulcerogenic potential. Med Chem Res 23, 503–517 (2014). https://doi.org/10.1007/s00044-013-0639-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-013-0639-8

Keywords

Navigation